三种抗菌药治疗呼吸道感染的疗效-成本分析  

Cost-effective Analysis on Treatment of Respiratory Tract Infection with Three Antibacterials

作　　者：任炜[1] 李飞[1] 苏治国[1] 于国英[1] 

机构地区：[1]青岛大学医学院附属医院,山东青岛266003

出　　处：《食品与药品》2009年第4期55-56,共2页Food and Drug

摘　　要：目的评估分析克林霉素磷酸酯注射液、注射用乳糖酸阿奇霉素、左氧氟沙星注射液3种不同类型的抗菌药治疗呼吸道感染的临床疗效及成本效益,寻求最经济有效的治疗方案。方法随机将104例呼吸道感染患者分为3组,运用药物经济学成本-效果分析方法进行评价。结果与结论3种抗菌药对呼吸道感染的有效率分别是85.3%、82.9%和88.6%,疗效满意且不良反应较轻,治疗方案无显著性差异。Objective To evaluate the clinical efficiencies of Clindamycin Phosphate Injection, Azithromycin Lactobionate for Injection, Levofloxacin Hydrochloride Injection against respiratory tract infection in emergency patients, and to find out the best cost-effective therapeutic protocol under the precondition of equivalent treatment efficiency. Methods One hundred and four patients with respiratory tract infection were randomly divided into three groups and the cost-effectiveness analysis （CEA） was used for the evaluation of the possible treatment protocols. Results ＆ Conclusion The effective rates of three antibacterials of Clindamycin Phosphate Injection, Azithromycin Lactobionate for Injection, Levofloxacin Hydrochloride Injection were 85.3 %, 82.9% and 88.6%, respectively. The three antibacterials were effective in the treatment of respiratory tract infection and the side effects were mild. There was no significant difference among three therapeutic protocols.

关 键 词：抗菌药 呼吸道感染 药物经济学 

分 类 号：R912[医药卫生—药学]